Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells

Cell Growth and Differentiation

Volumn 12, Issue 1, 2001, Pages 39-50

  Edsjo A ^a   Hallberg, B ^a   Fagerstrom S ^a   Larsson, C ^a   Axelson, H ^a   Pahlman S ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; NERVE GROWTH FACTOR; NEUROTRANSMITTER; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN RECEPTOR; NORADRENALIN; PROTEIN TRKC; PROTEIN TYROSINE KINASE A; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH CONE; HUMAN; HUMAN CELL; MARKER GENE; NEUROBLASTOMA CELL; NEUROSECRETORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BLOTTING, NORTHERN; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLAST GROWTH FACTORS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, PHASE-CONTRAST; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEUROBLASTOMA; NEURONS; NEUROTROPHIN 3; NOREPINEPHRINE; PHENOTYPE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-FOS; RAS PROTEINS; RECEPTOR, TRKA; RECEPTOR, TRKC; RNA; SIGNAL TRANSDUCTION; SYNAPTOPHYSIN; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035142327     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. A developmental model of neuroblastoma: Differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage
2. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma
3. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas
4. Multiple defects of the nerve growth factor receptor in human neuroblastomas
5. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma
6. Neurotrophin receptors tumor progression tumor maturation
7. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis
8. Expression of TrkC in favorable human neuroblastomas
9. Association of neurotrophin receptor expression and differentiation in human neuroblastoma
10. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor
11. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo
12. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells
13. The nerve growth factor family of receptors
14. Neurotrophic factors: An evolutionary perspective
15. Neurotrophic factors and their receptors
16. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development
17. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3
18. Molecular and biochemical characterization of the human trk proto-oncogene
19. Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts
20. A v-myc-immortalized sympathoadrenal progenitor cell line in which neuronal differentiation is initiated by FGF but not NGF
21. Isolation of the progenitor cells of the sympathoadrenal lineage from embryonic sympathetic ganglia with the SA monoclonal antibodies
22. CNTF, FGF, and NGF collaborate to drive the terminal differentiation of MAH cells into postmitotic neurons
23. Sympathetic neuroblasts undergo a developmental switch in trophic dependence
24. NT-3 stimulates sympathetic neuroblast proliferation by promoting precursor survival
25. Neurotrophins regulate sequential changes in neurotrophin receptor expression by sympathetic neurobtasts
26. A reciprocal cell-cell interaction mediated by NT-3 and neuregulins controls the early survival and development of sympathetic neuroblasts
27. TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo
28. Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture
29. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation
30. NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis
31. A 38,000-dalton membrane protein (p38) present in synaptic vesicles
32. r 38,000 characteristic of presynaptic vesicles
33. A complex consisting of pp60c-src/pp60c-srcN and a 38 kDa protein is highly enriched in growth cones from differentiated SH-SY5Y neuroblastoma cells
34. TrkC isoforms with inserts in the kinase domain show impaired signaling responses
35. Cell cycle-dependent activation of Ras
36. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways
37. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells
38. Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons
39. Neuronal differentiation triggered by blocking cell proliferation
40. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate
41. The trk proto-oncogene product: A signal transducing receptor for nerve growth factor
42. Deletion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis
43. Signal transduction by the neurotrophin receptors
44. PKCε, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells
45. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
46. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
47. Regulation of neuronal survival by the serine-threonine protein kinase Akt
48. Prenatal and postnatal requirements of NT-3 for sympathetic neuroblast survival and innervation of specific targets
49. Morphology and growth, tumorigenicity, and cytogenetics of human neurobtastoma cells in continuous culture
50. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
51. Determination of catecholamines in human plasma by high-performance liquid chromatography: Comparison between a new method with fluorescence detection and an established method with electrochemical detection
52. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
53. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene
54. Characterization, sequence, and expression of the cloned human neuropeptide Y gene
55. Human GAP-43 expression: Multiple start sites for initiation of transcription in differentiating human neuroblastoma cells
56. Structure of the FBJ murine osteosarcoma virus genome: Molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells
57. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor